Vericiguat as an adjunct to temozolomide therapy improves behavioral and tumor outcomes in experimental glioblastoma
Abstract
Glioblastoma (GBM) is an aggressive brain tumor with limited effective therapies. The standard agent, Temozolomide (TMZ) though beneficial, often induces neurocognitive side effects that compromise quality of life. This study examined whether combining Vericiguat; a soluble guanylate cyclase stimulator, with standard or reduced TMZ doses could enhance antitumor efficacy and behavioral outcomes while reducing adverse effects in a rat model of GBM. 80 male Wistar rats received intracerebral injections of C6 glioma cells and were assigned to eight groups: Sham, Tumor, Vehicle, TMZ 3.75 mg/kg, TMZ 7.5 mg/kg, Vericiguat 0.5 mg/kg, and their combinations. Behavioral assessments (open field, elevated plus maze, rotarod, passive avoidance, and social interaction) were performed on days 20-24. On day 25, brain tissues were analyzed histologically and immunohistochemically (Ki-67). Survival was monitored for three months. Combination therapy significantly improved anxiety-like behavior, motor coordination, learning, memory, and social interaction compared with untreated tumor-bearing rats. Co treatment also extended survival, reduced tumor proliferation (lower Ki-67 expression), and preserved brain tissue structure. Vericiguat combined with low-dose TMZ produced synergistic effects on tumor suppression and neurocognitive recovery in GBM rats. These findings suggest that Vericiguat may enhance TMZ efficacy, enabling dose reduction and minimizing TMZ induced neurotoxicity while…
Read the paper
Related studies
- Combining in silico and in vitro approaches to identification of potent inhibitor against phospholipase A2 (PLA2)
- In silico and in vitro studies: investigating the chemical composition, DFT, molecular docking, and dynamic simulation of Satureja candidissima (Munby) Briq essential oil as a potential antibacterial agent
- Quercetin combined with ciprofloxacin and gentamicin inhibits biofilm formation and virulence in Staphylococcus aureus
- In silico study of the mechanism of action, pharmacokinetic and toxicological properties of some N-methylanthranilates and their analogs
- Anticonvulsant Effects of Citronellal, Daidzin, and Phytol, Possibly Through GABAA Receptor and Voltage-Gated Sodium Channel Interaction Pathways: In Vivo and In Silico Studies
- 2-Phenylcyclopropylmethylamine (PCPMA) Derivatives as D3R-Selective Ligands for 3D-QSAR, Docking and Molecular Dynamics Simulation Studies
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.